Growth Metrics

Travere Therapeutics (TVTX) Net Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 198.34%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -14,223.53%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 453.08%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 53.46%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn -619.30%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -619.30%
Dec 31, 2025 -157.24%
Sep 30, 2025 870.50%
Jun 30, 2025 203.23%
Mar 31, 2025 119.37%
Dec 31, 2024 110.58%
Sep 30, 2024 -82.75%
Jun 30, 2024 84.83%
Mar 31, 2024 -117.87%
Dec 31, 2023 -157.11%
Sep 30, 2023 127.32%
Jun 30, 2023 3.84%
Mar 31, 2023 -11.39%
Dec 31, 2022 -169.60%
Sep 30, 2022 -216.10%
Jun 30, 2022 -15.48%
Mar 31, 2022 44.33%
Dec 31, 2021 63.59%
Sep 30, 2021 282.15%
Jun 30, 2021 -138.21%
Mar 31, 2021 1,275.15%
Dec 31, 2020 -3,959.00%
Sep 30, 2020 -253.88%
Jun 30, 2020 2,835.04%
Mar 31, 2020 114.00%
Dec 31, 2019 94.57%
Sep 30, 2019 -115.87%
Jun 30, 2019 -79.47%
Mar 31, 2019 13.77%
Dec 31, 2018 -12,932.18%
Sep 30, 2018 565.42%
Jun 30, 2018 -40.36%
Mar 31, 2018 -4,531.37%
Dec 31, 2017 -97.61%
Sep 30, 2017 276.48%
Jun 30, 2017 2,233.26%
Mar 31, 2017 106.06%
Dec 31, 2016 116.47%
Sep 30, 2016 -79.65%
Jun 30, 2016 -129.31%
Mar 31, 2016 -113.97%
Dec 31, 2015 -1,242.14%
Sep 30, 2015 191.67%
Jun 30, 2015 -79.08%
Mar 31, 2015 4,529.97%
Dec 31, 2014 -3.31%
Mar 31, 2014 -192.37%